NOTABLE HIRES AHMED GOODARZI, MD, arrives at Houston Methodist having completed a postdoctoral research fellowship in immunology at Harvard Medical School, as well as a fellowship in pulmonary and critical care medicine and an advanced fellowship in lung transplant at Baylor College of Medicine. Among Goodarzi’s primary interests are advanced lung disease and transplant, respiratory failure and extracorporeal lung assist devices.
ASHRITH GUHA, MD, is a heart failure and transplant cardiologist who joins Houston Methodist to lend his expertise in the areas of heart failure, transplant and pulmonary hypertension. Ashrith earned his medical degree in India, followed by residency training in internal medicine at The University of Texas Health Science Center at Houston and a fellowship in cardiology and heart failure from the University of Iowa. Ashrith also holds a master’s in public health in epidemiology from the University of Alabama at Birmingham.
CONSTANCE MOBLEY, MD, PHD, joins Houston Methodist from University of California, Los Angeles, as a liver transplant and hepatobiliary surgeon. Mobley brings added expertise in intensive care, having received fellowship training in surgical critical care at the University of Michigan after completing her surgical residency there. One of Mobley’s primary interests is in the management of acute and chronic liver failure and developing modalities to bridge critically ill patients to transplant.
BARRY TRACHTENBERG, MD, comes to Houston Methodist as a heart failure and transplant cardiologist, with a primary focus on advanced heart failure. Trachtenberg is a native Houstonian who received his fellowship training in general cardiology and advanced heart failure and transplant at the University of Miami. One of Trachtenberg’s goals is to start a cardio-oncology program at Houston Methodist.
JIHAD G. YOUSSEF, MD, joins Houston Methodist as a board-certified pulmonologist who is also certified in sleep medicine, internal medicine and critical care medicine. Antirejection therapy is one of Youssef’s areas of focus, and he has previously worked on novel antirejection therapy. Youssef has contributed to the development of aerosolized antirejection therapy to reduce the incidence of chronic lung transplant rejection and systemic side effects of antirejection medications. Youssef also has an interest in sleep-related breathing disorders and lung transplant. houstonmethodist.org/transplant